Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogenic Mesenchymal Stem Cells in Hemophilia
NCT02108132Phase 1Unknown
- Sponsor
- Cairo University
- Start
- Aug 2014
- Primary completion
- Aug 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of allogenic hepatocyte-like mesenchymal stem cells in hemophilia A, sponsored by Cairo University. Primary endpoint: Assessment of Safety / Efficacy at 2 years. Status: unknown.
02
Drugs
allogenic hepatocyte-like mesenchymal stem cells
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT02108132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02108132.